Transformer-based molecular generative model for antiviral drug design
-
Updated
Nov 20, 2024 - Python
Transformer-based molecular generative model for antiviral drug design
QSAR + Streamlit app for predicting pIC50 of small molecules against SARS-CoV-2 Replicase Polyprotein — Random Forest, PubChem fingerprints, ChEMBL data, interactive web interface
This project aims to develop a chemical probe of CHIKV-nsP3-macrodomain starting from a fragment screen
A central, online location for public viewing of the goals and progress of the GRFT project
Conservation-constrained, escape-aware CRISPR guide design for HSV-1. Finds that the sampling resolution of the public genome corpus, not repair biology, limits how low an escape probability can be demonstrated.
Official site for Allegheny Biosciences, LLC
Python code for implementing antiviral mass-balance in pre-harvest herbal plants.
Agenovir — independent third-party profile of a public API surface, by API Evangelist. Agenovir Corporation was a biotechnology company founded in 2014 to develop a novel class of human therapeutics targeting diseases caused by latent or persistent viral reservoirs. Built on CRISPR/Cas9 and other nuclease technology from the Stephen Quake lab at St
To associate your repository with the antiviral topic, visit your repo's landing page and select "manage topics."